FTSE MIB
34.249,77 +310,02 (+0,91%) Dow Jones
38.239,66 +153,86 (+0,40%) Nasdaq
15.927,90 +316,14 (+2,03%) Nikkei 225
37.934,76 +306,28 (+0,81%) Petrolio
83,66 +0,09 (+0,11%) Bitcoin EUR
59.333,04 -255,82 (-0,43%)
Ramsay Générale de Santé SA (GD6.F)
| Chiusura precedente | 12,35 |
| Aperto | 12,30 |
| Denaro | 12,35 x 89700 |
| Lettera | 12,55 x 88800 |
| Min-Max giorno | 12,30 - 12,30 |
| Intervallo di 52 settimane | 12,30 - 22,30 |
| Volume | |
| Media Volume | 0 |
| Capitalizzazione | 1,374B |
| Beta (5 anni mensile) | 0,14 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -0,11 |
| Prossima data utili | N/D |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | 02 dic 2014 |
| Stima target 1A | N/D |
GlobeNewswireRamsay Sante : provisional annual results at end of June 2023
PRESS RELEASE Paris, 23rd August 2023 Provisional annual results at the end of June 2023 Group revenue increased by 9.3% to €4.7bn supported by positive activity volume growth in all geographies and recent acquisitions in the Nordic countries. Revenue growth on a like-for-like basis of 7.0%. Group EBITDA decreased by 5.6% to €621.4m, impacted by lower subsidies, high salary and procurement inflation and staff shortage challenges. Group share of net result after tax of €49.4m or 1.1% of revenue m
- GlobeNewswire
Ramsay Sante : Results at the end of March 2023
PRESS RELEASEParis, 2 May 2023 13.5% total revenues growth for the third quarter of this financial year, up to €1.3bn total revenues, supported by a broad-based good dynamics and recent acquisitions in the Nordics countries. Growth on a like-for-like basis of 10.2%. Continuously playing a leading role in addressing the numerous headwinds impacting the healthcare sector in Europe. For the quarter, EBITDA decreased by €30m leading to €137m and 11.0% margin for this quarter, due to lower subsidies,
